Timelo Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$5.85M |
| 2 |
EFXT
Enerflex
EFXT
|
+$4.57M |
| 3 |
Toronto Dominion Bank
TD
|
+$2.72M |
| 4 |
Cenovus Energy
CVE
|
+$2.39M |
| 5 |
Telus
TU
|
+$2.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WW
WW International
WW
|
+$6.56M |
| 2 |
Altimmune
ALT
|
+$5.24M |
| 3 |
Middleby
MIDD
|
+$2.8M |
| 4 |
BCE
BCE
|
+$1.33M |
| 5 |
VRN
Veren
VRN
|
+$1.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 6.81% |
| 2 | Healthcare | 5.6% |
| 3 | Consumer Staples | 3.26% |
| 4 | Communication Services | 2.55% |
| 5 | Materials | 2.01% |
Similar funds
Timelo Investment Management's Q1 2024 Portfolio in Review
As of Q1 2024, Timelo Investment Management held 43 positions worth $263M, up 130% from $115M the previous quarter. Its ten largest holdings account for 85% of the portfolio.
Timelo Investment Management deployed $139M of net new capital in Q1 2024, opening 18 new positions and adding to 10 existing holdings. Its largest new stake was Keurig Dr Pepper: 190,000 shares worth $5.83M.
By sector, the portfolio is most concentrated in Energy at 6.8% of assets, up from 5.6% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Altimmune, an estimated $5.24M trimmed.
- Timelo Investment Management's largest Q1 2024 buy was Keurig Dr Pepper: 190,000 shares worth $5.83M.
- Timelo Investment Management added most to Profound Medical in Q1 2024, an estimated $2.04M increase.
- Timelo Investment Management's biggest Q1 2024 reduction was Altimmune, cutting an estimated $5.24M.
- Timelo Investment Management fully exited WW International in Q1 2024, selling an estimated $6.56M.
- Timelo Investment Management's ten largest holdings make up 85% of its $263M portfolio in Q1 2024.
- Timelo Investment Management opened 18 new positions and closed 9 in Q1 2024.
- Timelo Investment Management's portfolio value rose 130% quarter-over-quarter to $263M.
Based on Timelo Investment Management's 13F filing for Q1 2024, filed 13 May 2024.